CytomX is a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment. With a focus on revolutionizing the way we approach cancer, CytomX is developing Probody® therapeutics that have the potential to unlock the full power of anti-cancer medications in a safer and more effective manner. Their broad pipeline consists of multiple Probody programs currently progressing through clinical trials, offering hope for patients and the potential to change lives.

CytomX is driven by a mission to bring a new generation of life-changing treatment options to patients. They are actively seeking bold and innovative individuals to join their diverse team and help pioneer new approaches in the fight against cancer. Additionally, CytomX embraces diversity, equity, and inclusion, maintaining a culture that encourages individuals to be themselves, feel respected, and contribute to the company's corporate and individual objectives.

Headquartered in South San Francisco, CytomX is committed to making a difference in the lives of cancer patients. By combining groundbreaking science with a mission-driven culture, they are determined to destroy cancer, differently